top of page
Comprehensive Muscular 
Activity Profiler (CMAPPro™)
The Comprehensive Muscular Activity Profiler (CMAPPro) incorporates high performance data acquisition hardware and software to help evaluate soft tissue injuries. The device captures and quantifies information regarding the interactivity of muscles and nerves while a patient is in motion. An evidence based assessment tool, CMAPPro provides objective, reproducible and specific information to augment clinicians' expertise across the neuromuscular care delivery continuum. 
cmap1.png
cmap2.png
Patient Benefits:

  • Greatly enhances identification of soft tissue injuries.

  • CMAPPro is a non-invasive and non-loading evaluation. There are no needles and no heavy lifting involved during the evaluation.

  • Enables the provider to formulate more effective treatment plans assisting in recovery.

  • Promotes faster return-to-productivity both at work and at home.

  • Generates dynamic considerations to complement static tests such as MRIs, CT scans and X-rays.

pain.jpeg
Frequently Asked Questions:

  • Does the clinic generate revenue from the CMAPPro? Yes. Ask your representative for details.

  • Is the CMAPPro FDA Approved? Yes, as a Class III Medical Device.

  • How long does the assessment take? 15-60 minutes depending on the protocol administered.

  • Is there clinical studies to support this technology? Yes, there is scientific literature to support CMAPPro. Your representative can provide them to you.

  • Is there a cost to the clinic? No.

  • Is the clinic responsible for the billing? No.

How does it work?

  1. A thorough CMAPPro training will be provided to the office along with the monitoring system at no cost to the clinic.

  2. A healthcare provider will order the, in-office, test and which protocols to administer.

  3. An assessment report will be provided to the healthcare provider.

Is there clinical evidence?

  • A 6.8 times increase in the odds of case closure when there was concordance between CMAP results and the physician’s independent diagnoses. There was also a significant reduction of overall medical costs after the CMAP was conducted.

Source

Who should be tested?
What sites are tested?

  • Cervical

  • Thoracic

  • Lumbosacral

  • Hip/Groin

  • Shoulder

  • Median Nerve (Carpal Tunnel)

  • Lower Extremities

  • Ankle

  • Sciatica Plus

  • Based upon medical necessity, a healthcare provider will order the test. The ideal patient will be insured through Workers' Compensation. Prior authorization for commercial patients is provided.

bottom of page